285 related articles for article (PubMed ID: 23981665)
1. The long-term efficacy and safety of levetiracetam in a tertiary epilepsy centre.
Kang BS; Moon HJ; Kim YS; Lee ST; Jung KH; Chu K; Lee SK
Epileptic Disord; 2013 Sep; 15(3):302-10. PubMed ID: 23981665
[TBL] [Abstract][Full Text] [Related]
2. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy.
Li S; Cao J; Xiao N; Cai F
J Child Neurol; 2010 May; 25(5):609-13. PubMed ID: 19779208
[TBL] [Abstract][Full Text] [Related]
4. Levetiracetam: a long-term follow-up study of efficacy and safety.
Bauer J; Ben-Menachem E; Krämer G; Fryze W; Da Silva S; Kasteleijn-Nolst Trenité DG
Acta Neurol Scand; 2006 Sep; 114(3):169-76. PubMed ID: 16911344
[TBL] [Abstract][Full Text] [Related]
5. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
[TBL] [Abstract][Full Text] [Related]
6. An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy.
Abou-Khalil B; Hemdal P; Privitera MD
Seizure; 2003 Apr; 12(3):141-9. PubMed ID: 12651078
[TBL] [Abstract][Full Text] [Related]
7. Levetiracetam monotherapy in children with epilepsy.
Khurana DS; Kothare SV; Valencia I; Melvin JJ; Legido A
Pediatr Neurol; 2007 Apr; 36(4):227-30. PubMed ID: 17437904
[TBL] [Abstract][Full Text] [Related]
8. The safety and efficacy of add-on levetiracetam in elderly patients with focal epilepsy: a one-year observational study.
Werhahn KJ; Klimpe S; Balkaya S; Trinka E; Krämer G
Seizure; 2011 May; 20(4):305-11. PubMed ID: 21257324
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of levetiracetam: an add-on trial in children with refractory epilepsy.
Grosso S; Franzoni E; Coppola G; Iannetti P; Verrotti A; Cordelli DM; Marchiani V; Pascotto A; Spalice A; Acampora B; Morgese G; Balestri P
Seizure; 2005 Jun; 14(4):248-53. PubMed ID: 15911359
[TBL] [Abstract][Full Text] [Related]
10. Levetiracetam in children, adolescents and young adults with intractable epilepsy: efficacy, tolerability and effect on electroencephalogram--a pilot study.
Goldberg-Stern H; Feldman L; Eidlitz-Markus T; Kramer U; Perez S; Pollak L; Phatal-Valevski A
Eur J Paediatr Neurol; 2013 May; 17(3):248-53. PubMed ID: 23159714
[TBL] [Abstract][Full Text] [Related]
11. Seizure freedom is not adversely affected by early discontinuation of concomitant anti-epileptic drugs in the EULEV cohort of levetiracetam users.
Droz-Perroteau C; Marchal C; Dureau-Pournin C; Lassalle R; Jové J; Robinson P; Lavernhe G; Vespignani H; Moore N; Fourrier-Réglat A;
Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1183-9. PubMed ID: 22972760
[TBL] [Abstract][Full Text] [Related]
12. Pregabalin or placebo used adjunctively with levetiracetam in refractory partial-onset epilepsy: a post hoc efficacy and safety analysis in combined clinical trials.
Uthman BM; Almas M; Emir B; Giordano S; Leon T
Curr Med Res Opin; 2011 Jul; 27(7):1285-93. PubMed ID: 21561392
[TBL] [Abstract][Full Text] [Related]
13. Open label, long-term, pragmatic study on levetiracetam in the treatment of juvenile myoclonic epilepsy.
Specchio LM; Gambardella A; Giallonardo AT; Michelucci R; Specchio N; Boero G; La Neve A
Epilepsy Res; 2006 Sep; 71(1):32-9. PubMed ID: 16814521
[TBL] [Abstract][Full Text] [Related]
14. Levetiracetam as add-on therapy in generalised epilepsies.
Kumar SP; Smith PE
Seizure; 2004 Oct; 13(7):475-7. PubMed ID: 15324824
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of adjunctive levetiracetam therapy in pediatric intractable epilepsy.
Lee YJ; Kang HC; Kim HD; Lee JS
Pediatr Neurol; 2010 Feb; 42(2):86-92. PubMed ID: 20117743
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of levetiracetam in clinical practice: results of the SKATE trial from Belgium and The Netherlands.
Lambrechts DA; Sadzot B; van Paesschen W; van Leusden JA; Carpay J; Bourgeois P; Urbain E; Boon PA
Seizure; 2006 Sep; 15(6):434-42. PubMed ID: 16893660
[TBL] [Abstract][Full Text] [Related]
17. Long-term levetiracetam treatment in patients with epilepsy: 3-year follow up.
Kuba R; Novotná I; Brázdil M; Kocvarová J; Tyrlíková I; Mastík J; Rektor I
Acta Neurol Scand; 2010 Feb; 121(2):83-8. PubMed ID: 20003081
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of levetiracetam in children with refractory epilepsy as an add-on trial.
Tonekaboni SH; Ghazavi M; Karimzadeh P; Mahvelati F; Ghofrani M
Epilepsy Res; 2010 Aug; 90(3):273-7. PubMed ID: 20619606
[TBL] [Abstract][Full Text] [Related]
19. Levetiracetam in refractory epilepsy: a prospective observational study.
Mohanraj R; Parker PG; Stephen LJ; Brodie MJ
Seizure; 2005 Jan; 14(1):23-7. PubMed ID: 15642496
[TBL] [Abstract][Full Text] [Related]
20. [Clinical experience with levetiracetam for adults with epilepsy].
Barcs G; Szucs A
Ideggyogy Sz; 2007 Jan; 60(1-2):31-4. PubMed ID: 17432091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
